Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether mild liver impairment affects blood levels of
istradefylline in humans. Decreased liver function could possibly increase istradefylline
levels.